valrubicin
valrubicin is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Valstar. Available dosage form: solution, concentrate.
Drug details
- Generic Name
- valrubicin
- Brand Names
- Valstar
- Application Number
- NDA020892
- Sponsor
- Endo USA, Inc.
- NDC Codes
- 1
- Dosage Forms
- SOLUTION, CONCENTRATE
- Routes
- INTRAVESICAL
- Active Ingredients
- VALRUBICIN
Indications and Usage
1 INDICATIONS AND USAGE VALSTAR is an anthracycline topoisomerase inhibitor indicated for intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality. VALSTAR is an anthracycline topoisomerase inhibitor indicated for intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality. ( 1 )